Indeed, the low-dose insulin infusion shifted the IUGR-I myoblasts from the G0/G1 towards the S/G2/M cell cycle stages compared to both IUGR-S and CON-S myoblasts. The gene discussed is INS; the disease is fetal growth restriction.